- 米国企業
- Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc.VYGR
時価総額
$4.6億
PER
3.5倍
| 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
| Collaboration revenue | - | - | - | 8 | 104 | 171 | 37 | 41 | 250 |
| Research and development | - | - | - | 65 | 120 | 109 | 74 | 61 | 92 |
| General and administrative | - | - | - | 34 | 36 | 35 | 37 | 31 | 36 |
| Total operating expenses | - | - | - | 99 | 156 | 144 | 111 | 92 | 128 |
| Operating income (loss) | - | - | - | -91 | -52 | 27 | -74 | -51 | 122 |
| Interest income (expense) | - | - | - | 3 | 6 | 2 | -0 | 2 | 12 |
| Other income | - | - | - | -1 | 2 | 8 | 3 | 3 | 0 |
| Total other income, net | - | - | - | 3 | 8 | 9 | 2 | 4 | 12 |
| Income (loss) before income taxes | - | - | - | -88 | -44 | 37 | - | -46 | 134 |
| Income tax provision | - | - | - | -0 | - | - | - | 0 | 1 |
| Net income (loss) | -30 | -40 | -71 | -88 | -44 | 37 | -71 | -46 | 132 |
| Net unrealized gain (loss) on available-for-sale-securities | - | - | - | 0 | 0 | -0 | -0 | -0 | 0 |
| Total other comprehensive income (loss) | - | - | - | 0 | 0 | -0 | -0 | -0 | 0 |
| Comprehensive income (loss) | - | - | - | -88 | -44 | 37 | -71 | -46 | 133 |
| Earnings Per Share, Basic | - | - | - | - | - | 0.99 | -1.89 | -1.21 | 3.08 |
| Earnings Per Share, Diluted | - | - | - | - | - | 0.98 | -1.89 | -1.21 | 2.97 |